The Health Bureau (SSM) announced in a statement last night that it will start the administration of BioNTech mRNA jabs targeting the Omicron XBB subvariants for those aged from six months through 11 years tomorrow.
The appointments for the new vaccinations start at 10 a.m. today, the statement said.
The new vaccine for children aged from six months through 11 years will be provided at the Ilha Verde Health Centre and the Ocean Gardens Health Centre, the statement said.
Macau’s administration of BioNTech mRNA jabs targeting XBB for those aged 12 or over started in November last year.
BioNTech is a German biotechnical company.
The new BioNTech mRNA vaccine is a monovalent vaccine (aka univalent) that only contains components for the XBB subvariants, i.e., no longer contains components for the original COVID-19 strain.
The Health Bureau is recommending everyone aged 12 or over to receive a BioNTech mRNA monovalent XBB jab, regardless of whether they have previously been vaccinated against COVID-19.
According to yesterday’s statement, the Health Bureau now recommends everyone aged from 5 through 11 to also receive a BioNTech mRNA monovalent XBB jab, regardless of whether they have previously been vaccinated against COVID-19.
According to the statement, the bureau now recommends those aged from six months to four years inclusive to receive three XBB jabs if they have never received any COVID-19 jabs.
Those in this age group who have previously received one non-XBB jab are now recommended to receive two XBB jabs, the statement said.
According to the statement, those in this age group who have previously received two or more non-XBB jabs are now recommended to receive one XBB jab.
